People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Volastra Therapeutics, Inc. | — | Biotechnology | Series C | $105.3M | $170.7M | 2025 |
| Baboon Mega Corp, Inc. | — | Other | Series A | $11.4M | $32.6M | 2022 |
| Actinium Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $9.6M | $159.2M | 2011 |
| Rapalogix Health, Inc. | — | Biotechnology | Series A | $9.1M | $61.5M | 2023 |
| La Mend, Inc. | — | Other | Series A | $6.5M | $48.4M | 2019 |
David Nicholson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Nicholson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amy Schulman | 1 | 11 |
| Cameron Newton | 1 | 8 |
| Karen Howland | 1 | 5 |
| Robert Mittendorff | 1 | 5 |
| Brent Saunders | 1 | 5 |
| Luc Dochez | 1 | 4 |
| James Peyer | 1 | 3 |
| MICHAEL KUSHNER | 1 | 3 |
| David Southwell | 1 | 3 |
| Stefan Vitorovic | 1 | 3 |
| RICHARD SHERMAN | 1 | 3 |
| Ellie McGuire | 1 | 2 |
| Sandra Peterson | 1 | 2 |
| Jesse Derris | 1 | 2 |
| Rahul Mehta | 1 | 2 |
| Trey Sisson | 1 | 2 |
| Rosemary Mazanet | 1 | 2 |
| Arjun Zolot Balar | 1 | 1 |
| Samuel Bakhoum | 1 | 1 |
| Scott Drutman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.